Home › Criticism › Not a brain marker
No brain marker for gender identity
"A female brain in a male body" is an empty metaphor. Not a single brain study provides a marker that allows for an individual diagnosis. Yet this claim is sold as scientifically established — a creed disguised as neuroscience.
The Zhou Study (1995): Foundation Under a Myth
Dick Swaab and Jiang-Ning Zhou published research in Nature (1995) on the BSTc nucleus in six post-mortem brains of trans women. Conclusion: BSTc volume comparable to that of women. This heavily substantiated "evidence" is still cited three decades later — even though it does not hold up methodologically. Full debunk: Zhou brain research .
Four fatal problems
1. Sample size n=6 — zero statistical power. 2. All subjects had used estrogen for years; estrogen itself alters BSTc volume (Chung et al. 2002). The study therefore measures the effect of hormones, not of "being transgender". 3. BSTc dimorphism does not appear until adulthood — long after the onset of gender dysphoria in children. 4. Replication is lacking. Garcia-Falgueras (2008) repeated the errors instead of resolving them.
Meta-analyses undermine the claim
Guillamon et al. (2016) reviewed all neuroimaging studies and concluded that transgender brains have "their own phenotype" — expressly not the opposite sex. Joel et al. (2015, PNAS ) showed that brains do not exhibit a consistent "male" or "female" pattern anyway; they are mosaics. The male/female differences that do exist overlap massively. Anyone who reads this data honestly sees no "trans brains" — anyone who reads them ideologically sees what they want to see.
The ad-hoc saving of a dogma
When brain studies show no marker, the affirmative doctrine switches to: "gender identity does not have to be biological." A classic unfalsifiable retreat—the claim is adjusted to every negative result. At the same time, the practice continues: puberty blockers, hormones, mastectomies in healthy minors. The evidence is lacking; the interventions remain. See also no measurable marker and no genetic marker for the pattern. The Cass Review called the evidence for the entire practice "remarkably weak."
What remains: self-reporting
No gene, no brain scan, no blood value. The diagnosis relies entirely on what someone says they feel — unacceptable in any other medical domain as a basis for irreversible interventions. Anyone who drops the "transbrain" claim sees what lies beneath: a metaphysical claim disguised as a diagnosis.
Small, non-replicable, hormone-confounded differences — not a marker that allows for an individual diagnosis. Noise at the group level; useless at the individual level.
fMRI studies show no consistent transgender pattern. The variance between individuals consistently exceeds the difference between groups. Anyone who would use such a thing clinically would never receive a license.
Because the outcome is politically desirable. Negative studies are suppressed — see publication bias and fraud in this field.
Sources
- Guillamon, A., Junque, C., & Gómez-Gil, E. (2016). A Review of the Status of Brain Structure Research in Transsexualism. Archives of Sexual Behavior , 45(7). Springer
- Joel, D. et al. (2015). Sex beyond the genitalia: The human brain mosaic. PNAS , 112(50).
- Chung, W. C., De Vries, G. J., & Swaab, D. F. (2002). Sexual differentiation of the BST. J Neuroscience , 22.